The cyclin dependent kinase inhibitor 2 (CDKN2) gene on chromosome 9p2
1 is potentially involved in the genesis of many cancers and is curren
tly under intense investigation as a possible melanoma susceptibility
locus. We have analyzed 18 Australian melanoma kindreds for mutations
within the coding and neighboring splice junction portions of the CDKN
2 gene. In seven kindreds (including our six largest), CDKN2 mutations
were found to segregate with the putative melanoma chromosome previou
sly assigned by 9p haplotype analysis. These changes included the dupl
ication of a 24 bp repeat, a deleted C residue resulting in the introd
uction of a premature stop codon, and four single basepair changes cau
sing amino acid substitutions. Mutations segregated to 46 of 51 affect
ed individuals in these seven kindreds, with three apparent sporadic c
ases in one family and one in each of another two families. Penetrance
was variable (55-100%) among the different mutations. These data prov
ide additional strong support that the CDKN2 gene is the chromosome 9p
21 familial melanoma locus.